Supernus (SUPN) Reports Q2 Earnings: What Key Metrics Have to Say
SUPNSupernus Pharmaceuticals(SUPN) ZACKS·2024-08-07 09:02

For the quarter ended June 2024, Supernus Pharmaceuticals (SUPN) reported revenue of 168.33million,up24.2168.33 million, up 24.2% over the same period last year. EPS came in at 0.36, compared to -0.02intheyear−agoquarter.ThereportedrevenuecomparestotheZacksConsensusEstimateof0.02 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of 148.8 million, representing a surprise of +13.12%. The company delivered an EPS surprise of -2.70%, with the consensus EPS estimate being $0.37.While investors closely watch year-over-year changes in headline numbers -- revenue and earnin ...